Skip to main content

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry.

Pauletti G, Dandekar S, Rong H, Ramos L, Peng H, Seshadri R, Slamon DJ

Publication: J Clin Oncol (2000) • Vol 18 • Page 3651-64PMID: 11054438View on PubMed

Purpose

This paper conducted a comparative assessment of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) based detection of HER-2/neu overexpression in formalin-fixed, paraffin-embedded (FFPE) breast cancer specimens.

Conclusion

Due to an increased incidence of false positives, the authors identified IHC using the R60 antibody as superior to the HercepTest. Direct comparisons among FISH detection of HER-2/neu copy number and IHC detection of HER-2/neu overexpression revealed that FISH detection was more sensitive when using FFPE sections. Further, FISH detection was a more valuable predictor of patient prognosis than IHC using the R60 antibody.

Studies (2)

Purpose

The purpose of this study was to compare two IHC detection methods for HER-2/neu overexpression: the commercially available Herceptest, and the R60 antibody.

Summary of Findings

Using specimens identified as having high and low HER-2/neu copy number via FISH, two methods of IHC detection were compared for accuracy and sensitivity. Although sensitivity was reduced for both IHC methods compared to FISH, HercepTest analysis resulted in a higher instance of both false negatives (5%) and false positives (25%) compared to IHC analysis with the R60 antibody. Antigen retrieval used in conjunction with HercepTest analysis failed to improve results.
  • Biospecimens

    TissueBreast
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    ProteinImmunohistochemistry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Immunohistochemistry SpecificTechnology platform
    HercepTest
    R60 antibody